Guidance
Interesting shortcuts
EFFRA Members' Perspectives
News Dashboard
Structured Wiki
Search
FoF and Made in Europe Partnership
Demonstrators, pilots, prototypes
Exploitable result(s)
Significant innovations and lessons learned, training aspects
Report - Video - Presentation - Publication....?
Project clusters
Company perspectives
Manufacturing future products
Manufacturing performance characteristics
Technologies and enablers
ICT performance characteristics
Standards, technical committees and working groups
Contribution of R&I projects to standardisation
Regulatory and policy aspects
Standards - other classifications
Business model aspects
Pathways
MiE SRIA R&I Priorities
MiE WP26-27 Consultation - Potential Research Topics only
MiE WP26-27 Consultation and context pointers
MiE WP26-27 Consultation with pointers to WP25-27 consultation
MiE KPIs
Relevant (future) calls
EU-Programme-Call
NACE code
EFFRA Organisations - members
EFFRA WG pointers
Pathways
Pathways
Projects
Projects
Resources
Resources
Project ideas
Project ideas
People & organisations
People
Organisations
portal@effra.eu
Visit the EFFRA website
Login
Structured Wiki
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-HCO-2014
HCO-04-2014 Support for international infectious disease preparedness research
HCO-05-2014 Global Alliance for Chronic Diseases: prevention and treatment of type 2 diabetes
HCO-07-2014 ERA-NET: Establishing synergies between the Joint Programming on Neurodegenerative Diseases Research and Horizon 2020
HCO-08-2014 ERA-NET: Aligning national/regional translational cancer research programmes and activities
HCO-10-2014 ERA NET rare disease research implementing IRDiRC objectives
H2020-HCO-2015
HCO-06-2015 Global Alliance for Chronic Diseases. Prevention and treatment of lung diseases
HCO-11-2015 ERA NET Collaboration and alignment of national programmes and activities in the area of brain-related diseases and disorders of the nervous system
HCO-12-2015 ERA NET: Antimicrobial resistance
HCO-13-2015 ERA-NET: Cardiovascular disease
HCO-17-2015 Towards sustainability and globalisation of the Joint Programming Initiative on Neurodegenerative Diseases
H2020-IBA-SC1-CORONAVIRUS-2020-3
IBA-SC1-CORONAVIRUS-2020-3
H2020-IBA-SC1-GACD-2018
IBA-SC1-GACD-2018
H2020-PHC-2014-single-stage
PHC-15-2014 Clinical research on regenerative medicine
H2020-PHC-2014-two-stage
PHC-10-2014 Development of new diagnostic tools and technologies: in vitro devices, assays and platforms
PHC-13-2014 New therapies for chronic non-communicable diseases
PHC-17-2014 Comparing the effectiveness of existing healthcare interventions in the elderly
H2020-PHC-2015-single-stage_RTD
PHC-15-2015 Clinical research on regenerative medicine
H2020-PHC-2015-two-stage
PHC-11-2015 Development of new diagnostic tools and technologies: in vivo medical imaging technologies
PHC-14-2015 New therapies for rare diseases
PHC-16-2015 Tools and technologies for advanced therapies
PHC-18-2015 Establishing effectiveness of health care interventions in the paediatric population
H2020-SC1-2016-RTD
SC1-PM-09-2016 New therapies for chronic diseases
SC1-PM-11-2016-2017 Clinical research on regenerative medicine
H2020-SC1-2016-RTD-Zika
SC1-PM-22-2016 Addressing the urgent research gaps against the Zika virus and other emerging threats in Latin America
H2020-SC1-2017-Single-Stage-RTD
SC1-HCO-07-2017 Global Alliance for Chronic Diseases (GACD) prevention and management of mental disorders
SC1-PM-11-2016-2017 Clinical research on regenerative medicine
H2020-SC1-2017-Two-Stage-RTD
SC1-PM-08-2017 New therapies for rare diseases
SC1-PM-10-2017 Comparing the effectiveness of existing healthcare interventions in the adult population
H2020-SC1-2018-Single-Stage-RTD
SC1-BHC-04-2018 Rare Disease European Joint Programme Cofund
SC1-BHC-09-2018 Innovation platforms for advanced therapies of the future
SC1-BHC-16-2018 Global Alliance for Chronic Diseases (GACD) - Scaling-up of evidence-based health interventions at population level for the prevention and management of hypertension and/or diabetes
SC1-BHC-18-2018 Translational collaborative cancer research between Europe and the Community of Latin American and Caribbean States (CELAC)
SC1-BHC-23-2018 Novel patient-centred approaches for survivorship, palliation and/or end-of-life care
H2020-SC1-2018-Two-Stage-RTD
SC1-BHC-15-2018 New anti-infective agents for prevention and/or treatment of neglected infectious diseases (NID)
H2020-SC1-2019-Single-Stage-RTD
SC1-BHC-07-2019 Regenerative medicine: from new insights to new applications
SC1-HCO-15-2019 Support for the functioning of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)
H2020-SC1-2019-Two-Stage-RTD
SC1-BHC-14-2019 Stratified host-directed approaches to improve prevention, treatment and/or cure of infectious diseases
H2020-SC1-PHE-CORONAVIRUS-2020
SC1-PHE-CORONAVIRUS-2020
H2020-SMEINST-1-2014
PHC-12-2014-1 Clinical research for the validation of biomarkers and/or diagnostic medical devices
H2020-SMEINST-1-2015
PHC-12-2015-1 Clinical research for the validation of biomarkers and/or diagnostic medical devices
H2020-SMEINST-1-2016-2017
SMEInst-05-2016-2017 Supporting innovative SMEs in the healthcare biotechnology sector
H2020-SMEINST-2-2014
PHC-12-2014 Clinical research for the validation of biomarkers and/or diagnostic medical devices
H2020-SMEINST-2-2015
PHC-12-2015 Clinical research for the validation of biomarkers and/or diagnostic medical devices
H2020-SMEINST-2-2016-2017
SMEInst-05-2016-2017 Supporting innovative SMEs in the healthcare biotechnology sector